文献速递其他结缔组织病

舍格伦病的精准医学

Precision medicine in Sjögren's disease.
PubMed 文献 · Lancet Rheumatol · 2024-05-06

舍格伦病在临床和病理生理上具有异质性,精准医学并非总能适用;生物通路失调与疲劳、疼痛等症状或临床表现之间的关系常难以建立,这种临床与生物学分离也给临床试验终点定义带来挑战。本文综述了临床、实验室、组织学和生物分子分层方面的现有证据,并探讨分层数据如何指导精准医学和未来临床试验设计。

要点

  • 舍格伦病临床和病理生理异质性大,精准医学并非总能适用。
  • 生物通路失调与疲劳、疼痛等症状或临床表现的关系常难建立。
  • 临床与生物学分离给临床试验终点定义带来挑战。

核心结论

  • 舍格伦病临床和病理生理异质性大,精准医学并非总能适用;近年研究致力于通过分层模型将患者聚类为具有独特分子特征、生物标志物、临床特征和结局的同质亚组,以更好理解其异质性。

研究设计与样本

  • 本文为综述,讨论舍格伦病临床、实验室、组织学和生物分子分层方面的现有证据,并探讨分层数据如何指导精准医学和未来临床试验设计。

主要发现

  • 舍格伦病患者中,失调的生物通路与疲劳、疼痛等症状或临床表现之间的关系常难以建立。
  • 这种临床与生物学分离也给临床试验中适当临床终点的定义带来挑战。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sjögren's disease is a clinically and pathophysiologically heterogeneous disease to which precision medicine, on the basis of clinical and biological heterogeneity, has been not always applicable. In patients with Sjögren's disease, the relationship between dysregulated biological pathways and symptoms such as fatigue and pain or clinical manifestations is often difficult to establish. This clinical and biological dissociation also poses challenges when defining appropriate clinical endpoints for clinical trials. In the last few years, however, research efforts have been focused on gaining a better understanding of the considerable heterogeneity of Sjögren's disease by developing stratification models aimed at clustering patients with this condition into homogenous subgroups characterised by distinctive molecular signatures, biomarkers, clinical features, and outcomes. In this Review, we discuss current evidence regarding clinical, laboratory, histological, and biomolecular stratification in Sjögren's disease and examine how available stratification data can guide precision medicine and inform the design of future clinical trials.

来源:Lancet Rheumatol,查看原文。版权归原作者所有。

引用

  1. Gandolfo S, Bombardieri M, Pers JO, et al. Precision medicine in Sjögren's disease. Lancet Rheumatol. 2024. PMID: 38723653. doi:10.1016/S2665-9913(24)00039-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。